Management of spasticity in multiple sclerosis by intrathecal baclofen-Reference-Cited by-同舟云学术

Management of spasticity in multiple sclerosis by intrathecal baclofen

Published: Issue: Volume: Page:189-192
ISSN:
Container-title:Operative Neuromodulation
language:
Short-container-title:

Author:

Dario Alessandro,Tomei G.

Publisher

Springer Vienna

Link

http://link.springer.com/content/pdf/10.1007/978-3-211-33079-1_26.pdf

Reference25 articles.

1. Akman MN, Loubser PG, Donovan WH (1993) Intrathecal baclofen: does tolerance occur? Paraplegia 31: 516–520

2. Boviatsis EJ, Kouyialis AT, Korfias S, Sakas DE (2005) Functional outcome of intrathecal baclofen administration for severe spasticity. Clin Neurol Neurosurg 107: 289–295

3. Bramanti P, D’Aleo G, Rifici C, Alagna A, Cannata A, Sessa E, Di Bella P, Marra G (2004) Quality of life of patients with telemetric pumps for intrathecal baclofen infusion: data and limitations of assessment scales. Funct Neurol 19: 227–231

4. Dario A, Scamoni C, Picano M, Fortini G, Cuffari S, Tomei G (2005) The infection risk of intrathecal drug infusion pumps after multiple refill procedures. Neuromodulation 8: 36–39

5. Dario A, Tomei G (2004) A benefit-risk assessment of baclofen in severe spinal spasticity. Drug Saf 27: 799–818

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pain Management in Multiple Sclerosis: a Review of Available Treatment Options;Current Treatment Options in Neurology;2019-11-27

2. Central pain states;Essentials of Pain Medicine;2011

3. Intrathecal administration of GABA agonists in the vegetative state;Progress in Brain Research;2009